SANFORD-BURNHAM MEDICAL RES INST has a total of 31 patent applications. Its first patent ever was published in 2010. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are SANFORD BURNHAM MED RES INST, PETER MACCALLUM CANCER INST and TULARIK INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Canada | 5 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Brazil | 1 | |
#7 | Japan | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | Russian Federation | 1 | |
#11 | Singapore | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Computer technology |
# | Name | Total Patents |
---|---|---|
#1 | Pinkerton Anthony B | 6 |
#2 | Ware Carl F | 3 |
#3 | Pellecchia Maurizio | 3 |
#4 | Cosford Nicholas David Peter | 3 |
#5 | Terskikh Alexey V | 3 |
#6 | Millan Jose Luis | 2 |
#7 | Bradley Linda M | 2 |
#8 | Hassig Christian A | 2 |
#9 | Vamos Mitchell Dennis | 2 |
#10 | Ruoslahti Erkki | 2 |
Publication | Filing date | Title |
---|---|---|
WO2016140973A1 | Quinolinones as inhibitors of translation initiation complex | |
CA2953706A1 | Psgl-1 modulators and uses thereof | |
CA2950911A1 | Use of inhibitor of apoptosis protein (iap) antagonists in hiv therapy | |
WO2016137436A1 | Methods and composition for treating cancer | |
US2016232293A1 | Drug sensitivity biomarkers and methods of identifying and using drug sensitivity biomarkers | |
US2016214951A1 | EBI2 modulators | |
US2016145308A1 | Compositions and methods for targeted endometriosis treatment | |
US2015212086A1 | Diagnosis and treatment of brain tumor |